biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0e1-01a-11w-a071-09
biospecimen_aliquot__bcr_aliquot_uuid	48706085-54be-4ea7-922e-46757a0b2979
biospecimen_aliquot__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0e1-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0089490716
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-09-08
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	3
biospecimen_aliquot__plate_id	a071
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0e1-01a-11w
biospecimen_analyte__bcr_analyte_uuid	29474b5d-cb09-45e6-9441-8515a308021b
biospecimen_analyte__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0e1-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0e1
biospecimen_diagnostic_slides__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0e1-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	257eb36a-1008-4890-927b-204ef05dbe90
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0e1
biospecimen_normal_control__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_portion__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0e1-01a-11
biospecimen_portion__bcr_portion_uuid	114ebb10-6913-4f9c-871a-255e5687fffc
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0e1-01a
biospecimen_portion__date_of_creation	2010-06-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0e1-01a-11w
biospecimen_protocol__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0e1-01a
biospecimen_protocol__experimental_protocol_type	repli-g
biospecimen_sample__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0e1-01a
biospecimen_sample__bcr_sample_uuid	dcf7829e-abaa-435f-b41d-a2bcfde5d66a
biospecimen_sample__days_to_collection	301
biospecimen_sample__initial_weight	990
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0e1.891f4c63-8207-4cb8-ab59-a970cc6f1a1a.pdf
biospecimen_sample__pathology_report_uuid	891f4c63-8207-4cb8-ab59-a970cc6f1a1a
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_shipment_portion__bcr_sample_barcode	tcga-bh-a0e1-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	248d3774-ea4c-49e1-ba9e-fd010dc60978
biospecimen_shipment_portion__center_id	30
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a21v
biospecimen_shipment_portion__portion_number	41
biospecimen_shipment_portion__portion_sequence	4
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-bh-a0e1-01a-41-a21v-30
biospecimen_shipment_portion__shipment_portion_day_of_shipment	3
biospecimen_shipment_portion__shipment_portion_month_of_shipment	4
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0e1-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0e1-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	01da1142-7d58-419d-998b-acd3be403d31
biospecimen_slide__image_file_name	tcga-bh-a0e1-01a-01-tsa.01da1142-7d58-419d-998b-acd3be403d31.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	1
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	40
biospecimen_slide__percent_stromal_cells	4
biospecimen_slide__percent_tumor_cells	55
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0e1
biospecimen_tumor_sample__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
clinical_drug__bcr_drug_barcode	tcga-bh-a0e1-d4604
clinical_drug__bcr_drug_uuid	87ac4755-e995-47cf-90e0-fdd408456387
clinical_drug__bcr_patient_barcode	tcga-bh-a0e1
clinical_drug__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
clinical_drug__form_completion_date	2010-11-30
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	349
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0e1-f4631
clinical_follow_up__bcr_followup_uuid	cfd1b195-8dd2-421f-b5ec-e88e05b12781
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0e1
clinical_follow_up__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
clinical_follow_up__form_completion_date	2010-11-16
clinical_follow_up__last_contact_days_to	477
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-bh-a0e1
clinical_nte__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
clinical_patient__age_at_diagnosis	52
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant|left
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-bh-a0e1
clinical_patient__bcr_patient_uuid	606fbc6a-b41b-441d-9401-51e54912bf5e
clinical_patient__birth_days_to	-19192
clinical_patient__cent17_copy_number	1.67
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	2+
clinical_patient__er_positivity_method	h-score 180
clinical_patient__er_positivity_scale_other	h-score
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	70-79%
clinical_patient__form_completion_date	2010-11-9
clinical_patient__gender	female
clinical_patient__her2_and_cent17_cells_count	40
clinical_patient__her2_cent17_ratio	1.69
clinical_patient__her2_copy_number	2.81
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	477
clinical_patient__lymph_nodes_examined_count	17
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__margin_status	negative
clinical_patient__menopause_status	peri (6-12 months since last menstrual period)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0e1
clinical_patient__pr_positivity_define_method	h-score 245
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_positivity_scale_other	h-score
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	50-59%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0E1-01A-11W-A071-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0E1-01A-11W-A071-09.bed.meta
manually_curated__id	tcga-bh-a0e1-01a-11w-a071-09
manually_curated__md5sum	ea8c3b9abb4d9f8adca20292effb71fc
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	48706085-54be-4ea7-922e-46757a0b2979
manually_curated__tumor_tag	brca
